Li Z, Liu X, Li Z, Xiao Z, Chen G, Li Y
Invest Ophthalmol Vis Sci. 2025; 66(3):8.
PMID: 40042874
PMC: 11892529.
DOI: 10.1167/iovs.66.3.8.
Lei H, Hu J, Zhu J, Li R, Zhao Y, Zhao Y
Front Oncol. 2025; 15:1443890.
PMID: 40027134
PMC: 11867951.
DOI: 10.3389/fonc.2025.1443890.
Sasaki E, Asanuma H, Momose H, Maeyama J, Moriyama S, Nagata N
NPJ Vaccines. 2025; 10(1):28.
PMID: 39934182
PMC: 11814125.
DOI: 10.1038/s41541-025-01086-0.
Zhang M, Lv H, Bai X, Ruan G, Li Q, Lin K
Immun Ageing. 2025; 22(1):4.
PMID: 39794776
PMC: 11721460.
DOI: 10.1186/s12979-024-00494-5.
Grewe I, Friedrich M, Dieck M, Spohn M, Ly M, Krahling V
Front Immunol. 2025; 15:1500615.
PMID: 39749328
PMC: 11693667.
DOI: 10.3389/fimmu.2024.1500615.
Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults.
Kometani K, Yorimitsu T, Jo N, Yamaguchi E, Kikuchi O, Fukahori M
Front Immunol. 2024; 15:1455334.
PMID: 39717779
PMC: 11663736.
DOI: 10.3389/fimmu.2024.1455334.
HMGA1 influence on iron-induced cell death in Tfh cells of SLE patients.
Zhao S, Chen X, Chang B, Tian B
Cell Biol Toxicol. 2024; 41(1):6.
PMID: 39707065
PMC: 11662042.
DOI: 10.1007/s10565-024-09955-5.
Dnmt3a-dependent DNA methylation enforces lineage commitment and preserves functionality of memory Th1 and Tfh cells.
Perkins B, Novis C, Novis C, Baessler A, Sircy L, Thomas M
bioRxiv. 2024; .
PMID: 39677644
PMC: 11642886.
DOI: 10.1101/2024.12.03.623450.
Interleukin 9 mediates T follicular helper cell activation to promote antibody responses.
Sato T, Ikegami I, Yanagi M, Ohyu T, Sugaya T, Shirato S
Front Immunol. 2024; 15:1441407.
PMID: 39403384
PMC: 11471543.
DOI: 10.3389/fimmu.2024.1441407.
RNA sequencing and multiplexed immunohistochemistry reveal the factors for postoperative recurrence of stage IB-IIA cervical squamous cell carcinoma.
Wu M, Li B, Shi L, Yang L, Liang C, Wang T
Discov Oncol. 2024; 15(1):422.
PMID: 39254825
PMC: 11387578.
DOI: 10.1007/s12672-024-01283-8.
Identification of an Amino Acid Metabolism Reprogramming Signature for Predicting Prognosis, Immunotherapy Efficacy, and Drug Candidates in Colon Cancer.
Du F, Wu X, He Y, Zhao S, Xia M, Zhang B
Appl Biochem Biotechnol. 2024; 197(2):714-734.
PMID: 39222169
DOI: 10.1007/s12010-024-05049-4.
A review of CD4 T cell differentiation and diversity in dogs.
Lang H, Osum K, Friedenberg S
Vet Immunol Immunopathol. 2024; 275:110816.
PMID: 39173398
PMC: 11421293.
DOI: 10.1016/j.vetimm.2024.110816.
Coordinated expansion of memory T follicular helper and B cells mediates spontaneous clearance of HCV reinfection.
Eisa M, Gomez-Escobar E, Bedard N, Abdeltawab N, Flores N, Mazouz S
Front Immunol. 2024; 15:1403769.
PMID: 38947319
PMC: 11211980.
DOI: 10.3389/fimmu.2024.1403769.
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.
Zhong L, Zhang W, Liu H, Zhang X, Yang Z, Wen Z
Nat Commun. 2024; 15(1):5310.
PMID: 38906867
PMC: 11192767.
DOI: 10.1038/s41467-024-49546-w.
Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia.
Fang Q, Lu X, Zhu Y, Lv X, Yu F, Ma X
Cell Rep Med. 2024; 5(6):101614.
PMID: 38897173
PMC: 11228807.
DOI: 10.1016/j.xcrm.2024.101614.
In Situ Characterization of Human Follicular Helper CD4 T Cells.
Orfanakis M, Molyvdas A, Petrovas C
Methods Mol Biol. 2024; 2813:281-293.
PMID: 38888784
DOI: 10.1007/978-1-0716-3890-3_18.
Correlation between circulating T follicular helper cell levels after infection and a decreased risk of COVID-19 re-infection.
Feng J, Pu Z, Li R, Li Y, Qin X, Zhang H
Virol Sin. 2024; 39(4):699-701.
PMID: 38852919
PMC: 11401467.
DOI: 10.1016/j.virs.2024.06.002.
Identification of the Expression of TIE1 and Its Mediated Immunosuppression in Gastric Cancer.
Gong Z, Zheng Q, Li B, Wang H, Chen H, Lin S
J Cancer. 2024; 15(10):2994-3009.
PMID: 38706903
PMC: 11064258.
DOI: 10.7150/jca.90891.
Generating prophylactic immunity against arboviruses in vertebrates and invertebrates.
Rawle D, Hugo L, Cox A, Devine G, Suhrbier A
Nat Rev Immunol. 2024; 24(9):621-636.
PMID: 38570719
DOI: 10.1038/s41577-024-01016-6.
Mapping the immune terrain in lung adenocarcinoma progression: Tfh-like cells in tertiary lymphoid structures.
Gong J, Yu D
Cell Oncol (Dordr). 2024; 47(4):1493-1496.
PMID: 38491999
DOI: 10.1007/s13402-024-00936-8.